Melanotan 1 (MT-1) Research Guide
Melanotan 1 is the more selective alpha-MSH analogue, focused primarily on MC1R activation in melanocytes. Marketed as afamelanotide, it received FDA approval in 2019 for treatment of erythropoietic protoporphyria, making it one of the few
Read article →